MMPP’s unique mechanism of action, which not only scavenges ROS but also inhibits CREB transcriptional activity, particularly in the kidney and liver, suggests that MMPP could be a promising treatment for ADPKD. This evidence concerns the gene CREB1 and autosomal dominant polycystic kidney disease.